These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14390171)

  • 1. [Acute allergic myocarditis after vaccination against scarlet fever].
    LABOHY L; PICK J
    Cas Lek Cesk; 1952 Mar; 91(12):363-8. PubMed ID: 14390171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problem of active immunization against scarlet fever and of its recurrence].
    ZAHRADNICKY J
    Cesk Epidemiol Mikrobiol Imunol; 1953 Aug; 2(4):270-6. PubMed ID: 13209653
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of scarlet fever; studies during a Berlin epidemic. II..].
    WIESENER H
    Dtsch Med Wochenschr; 1954 Sep; 79(36):1320-3. PubMed ID: 13220047
    [No Abstract]   [Full Text] [Related]  

  • 4. [Result of immunization against diphtheria and scarlet fever with associated preparation].
    PAVLOV P; BALAIAN L
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):10-4. PubMed ID: 13282441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Purified adsorbed scarlet fever toxin. III. Result of active immunization against scarlet fever with purified adsorbed scarlet fever toxin].
    PAVLOV PV; MITEL'MAN SL; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):11-5. PubMed ID: 13605085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scarlet fever vaccination].
    TAMASI G
    Gyermekgyogyaszat; 1953 Jun; 4(6):161-6. PubMed ID: 13084020
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventive immunization against scarlet fever.
    TAMASI G
    Ther Hung; 1954; 3():25-8. PubMed ID: 13247270
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of scarlet fever immunization].
    OSTER H
    Offentl Gesundheitsdienst; 1953 Jul; 15(4):122-6. PubMed ID: 13099794
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of active immunization against scarlet fever by depot preparations].
    MITEL'MAN SL
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):3-8. PubMed ID: 13605083
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute non-specific myocarditis in scarlet fever and acute haemolytic tonsillitis A clinical investigation of 3,069 cases of scarlet fever, 798 cases of acute tonsillitis, and 333 cases of haemolytic streptococcus carriers.
    BENGTSSON E; BIRKE G; WINGSTRAND H
    Cardiologia (Basel); 1951; 18(6):360-74. PubMed ID: 14870166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Scarlet fever epidemic during year 1929 in Chile].
    Laval R E
    Rev Chilena Infectol; 2009 Apr; 26(2):168-72. PubMed ID: 19621150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scarlet fever as a nosocomial disease and methods for its prevention].
    KURITSYNA DA
    Tr Leningr Sanitarnogig Med Inst; 1957; 32():63-71. PubMed ID: 13569567
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of scarlet fever with sulfonamide].
    NASSO S; CATTANEO P
    Minerva Pediatr; 1957 Apr; 9(17):471-80. PubMed ID: 13451446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Specific prevention of scarlet fever].
    Ströder J
    Med Klin; 1978 Feb; 73(6):216. PubMed ID: 622069
    [No Abstract]   [Full Text] [Related]  

  • 15. [Association of scarlet fever with vaccination against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():105-6. PubMed ID: 14349283
    [No Abstract]   [Full Text] [Related]  

  • 16. [New trends in prevention of scarlet fever; attempted antibiotic prophylaxis].
    FORTE M; CANAZZA S
    Riv Ital Ig; 1957; 17(7-8):368-79. PubMed ID: 13519007
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of throat swab in prevention of scarlet fever?].
    Fenner O
    Munch Med Wochenschr; 1969 Mar; 111(11):625. PubMed ID: 4892700
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on the effectiveness of various scarlet fever antigens used in combination with other antigens in multiple antigen preparations.
    VOLK VK; TOP FH; BUNNEY WE
    Am J Public Health Nations Health; 1953 Jul; 43(7):833-9. PubMed ID: 13065535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serologic prevention of scarlet fever. V. Serologic prevention of contact scarlet fever in living quarters].
    MAUERMAN OE; IRTLACH BI; GIRSHIK BI
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Feb; 2():17-23. PubMed ID: 14375268
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the theoretical basis for a rational complex of measures for controlling scarlet fever].
    Dodonov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Sep; 46(9):55-60. PubMed ID: 4187899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.